Cargando…
Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19
The global coronavirus disease 2019 (COVID-19) has become one of the biggest threats to the world since 2019. The respiratory and gastrointestinal tracts are the main targets for severe acute respiratory syndrome coronavirus 2 infection for they highly express angiotensin-converting enzyme-2 and tra...
Autores principales: | Yao, Yang, Liu, Zhu-Jun, Zhang, Yu-Kun, Sun, Hui-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827583/ https://www.ncbi.nlm.nih.gov/pubmed/36632313 http://dx.doi.org/10.3748/wjg.v28.i48.6811 |
Ejemplares similares
-
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
por: Zhang, Jilei, et al.
Publicado: (2020) -
COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms
por: Du, Min, et al.
Publicado: (2022) -
Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
por: Xue, Weijie, et al.
Publicado: (2023) -
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
por: Zhong, Peijie, et al.
Publicado: (2020) -
Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer
por: Wang, Li-Yan, et al.
Publicado: (2020)